Dr David M Armesto, MD | |
2025 Technology Pkwy, Ste 103, Mechanicsburg, PA 17050-9400 | |
(717) 791-2580 | |
(717) 791-2588 |
Full Name | Dr David M Armesto |
---|---|
Gender | Male |
Speciality | Ophthalmology |
Experience | 43 Years |
Location | 2025 Technology Pkwy, Mechanicsburg, Pennsylvania |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1699778514 | NPI | - | NPPES |
001283789 | Medicaid | PA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | MD046411L (Pennsylvania) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Lehigh Valley Eye Center, P.c. | 3072593508 | 57 |
News Archive
Scientists thought they basically knew how the most common drugs used to treat type 2 diabetes worked, but a new study from the Florida campus of The Scripps Research Institute (TSRI) reveals unexpected new aspects of the process. These findings could eventually lead to more potent anti-diabetic drugs with fewer serious side effects.
A Binghamton University researcher hopes to give doctors a more accurate way of determining a patient's risk of heart attack or stroke.
The phase I clinical study will enroll 20 patients with advanced solid cancers (including most common tumor types), and is the culmination of more than a decade of work by a team of researchers led by Professor Esther H. Chang, Ph.D. at the Lombardi Comprehensive Cancer Center.
Spinal Restoration, Inc. announced today it has received a Special Protocol Assessment concurrence letter from the U.S. Food and Drug Administration (FDA) for the design of its Phase 3 study of the Biostat System for the treatment of chronic discogenic low back pain.
Maternal/child nurses are at the forefront of efforts to design and implement effective quality improvement (QI) programs to improve care for mothers and infants throughout labor and delivery, according to the special September/October issue of MCN: The American Journal of Maternal/Child Nursing.
› Verified 2 days ago
Entity Name | Family Eye Group Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1588616924 PECOS PAC ID: 7416944046 Enrollment ID: O20040427000724 |
News Archive
Scientists thought they basically knew how the most common drugs used to treat type 2 diabetes worked, but a new study from the Florida campus of The Scripps Research Institute (TSRI) reveals unexpected new aspects of the process. These findings could eventually lead to more potent anti-diabetic drugs with fewer serious side effects.
A Binghamton University researcher hopes to give doctors a more accurate way of determining a patient's risk of heart attack or stroke.
The phase I clinical study will enroll 20 patients with advanced solid cancers (including most common tumor types), and is the culmination of more than a decade of work by a team of researchers led by Professor Esther H. Chang, Ph.D. at the Lombardi Comprehensive Cancer Center.
Spinal Restoration, Inc. announced today it has received a Special Protocol Assessment concurrence letter from the U.S. Food and Drug Administration (FDA) for the design of its Phase 3 study of the Biostat System for the treatment of chronic discogenic low back pain.
Maternal/child nurses are at the forefront of efforts to design and implement effective quality improvement (QI) programs to improve care for mothers and infants throughout labor and delivery, according to the special September/October issue of MCN: The American Journal of Maternal/Child Nursing.
› Verified 2 days ago
Entity Name | Lehigh Valley Eye Center, P.c. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1356330369 PECOS PAC ID: 3072593508 Enrollment ID: O20040723000789 |
News Archive
Scientists thought they basically knew how the most common drugs used to treat type 2 diabetes worked, but a new study from the Florida campus of The Scripps Research Institute (TSRI) reveals unexpected new aspects of the process. These findings could eventually lead to more potent anti-diabetic drugs with fewer serious side effects.
A Binghamton University researcher hopes to give doctors a more accurate way of determining a patient's risk of heart attack or stroke.
The phase I clinical study will enroll 20 patients with advanced solid cancers (including most common tumor types), and is the culmination of more than a decade of work by a team of researchers led by Professor Esther H. Chang, Ph.D. at the Lombardi Comprehensive Cancer Center.
Spinal Restoration, Inc. announced today it has received a Special Protocol Assessment concurrence letter from the U.S. Food and Drug Administration (FDA) for the design of its Phase 3 study of the Biostat System for the treatment of chronic discogenic low back pain.
Maternal/child nurses are at the forefront of efforts to design and implement effective quality improvement (QI) programs to improve care for mothers and infants throughout labor and delivery, according to the special September/October issue of MCN: The American Journal of Maternal/Child Nursing.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr David M Armesto, MD 2025 Technology Pkwy, Ste 103, Mechanicsburg, PA 17050-9400 Ph: (717) 791-2580 | Dr David M Armesto, MD 2025 Technology Pkwy, Ste 103, Mechanicsburg, PA 17050-9400 Ph: (717) 791-2580 |
News Archive
Scientists thought they basically knew how the most common drugs used to treat type 2 diabetes worked, but a new study from the Florida campus of The Scripps Research Institute (TSRI) reveals unexpected new aspects of the process. These findings could eventually lead to more potent anti-diabetic drugs with fewer serious side effects.
A Binghamton University researcher hopes to give doctors a more accurate way of determining a patient's risk of heart attack or stroke.
The phase I clinical study will enroll 20 patients with advanced solid cancers (including most common tumor types), and is the culmination of more than a decade of work by a team of researchers led by Professor Esther H. Chang, Ph.D. at the Lombardi Comprehensive Cancer Center.
Spinal Restoration, Inc. announced today it has received a Special Protocol Assessment concurrence letter from the U.S. Food and Drug Administration (FDA) for the design of its Phase 3 study of the Biostat System for the treatment of chronic discogenic low back pain.
Maternal/child nurses are at the forefront of efforts to design and implement effective quality improvement (QI) programs to improve care for mothers and infants throughout labor and delivery, according to the special September/October issue of MCN: The American Journal of Maternal/Child Nursing.
› Verified 2 days ago
John Whetten Pratt, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 890 Century Dr, Mechanicsburg, PA 17055 Phone: 717-697-1414 Fax: 717-697-4921 | |
Stephanie Arlotti, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 890 Century Dr, Mechanicsburg, PA 17055 Phone: 717-697-1414 Fax: 717-697-4921 | |
Michael L Szmodis, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 890 Century Drive, Mechanicsburg, PA 17055 Phone: 717-697-1414 Fax: 717-697-4921 | |
Robert Lester Shindler, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2402 Ascott Way, Mechanicsburg, PA 17055 Phone: 717-697-4378 Fax: 717-697-4378 | |
Dr. Peter J Sakol, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2025 Technology Parkway, Suite 204, Mechanicsburg, PA 17050 Phone: 717-732-9000 Fax: 717-732-9011 | |
Dr. V. Eugene Kilmore, Jr., M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 890 Century Dr, Mechanicsburg, PA 17055 Phone: 717-697-1414 Fax: 717-697-4921 | |
Dr. Sandeep Kumar Kakaria, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2005 Technology Pkwy, Suite 230, Mechanicsburg, PA 17050 Phone: 717-695-9355 Fax: 717-695-9356 |